Weslyn Friley, Ph.D Director of Bioanalytical
Weslyn brings over 13 years of experience working and managing operations in the field of bioanalysis, as well as ADME and DMPK programs and has experience in working in GLP, GCLP and CLIA regulated environments.
Prior to joining Invitrox, Weslyn was responsible for and managed the analytical services operations at Qualyst Transporter Solutions. At Qualyst, Weslyn provided operational and technical support for bioanalytical aspects of the design and development of in vitro drug-drug interaction studies to answer client specific questions for their compounds. Weslyn also served on the Research and Development Committee at Qualyst for the development of new products and services in support of in vitro models for drug development, natural products, and chemical toxicology.
As a senior project manager at Tandem Labs, Weslyn was responsible for overall management and conduct of Clinical, CLIA, GLP, and non-GLP bioanalytical studies placed by assigned clients and championed the establishment of a CLIA program at Tandem Labs. As one of the primary method development chemists, Weslyn was responsible for the method development and validation of endogenous methods for use as biomarkers or in companion diagnostics.
Weslyn graduated from Virginia Tech in 2003 with a BS in Biochemistry, BA in Chemistry, Biochemistry and Organic Chemistry and obtained her PhD in 2008 studying the Molecular Analyses of Melanins and Neuromelanins at Duke University and was a member of the Phi Lambda Upsilon Honor Fraternity.